4.8 Review

Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy

Kewei Wang et al.

Summary: In this study, a clustered nanosystem was designed to overcome hypoxic resistance in tumors and enhance chemoimmunotherapy. This system utilized tumor acidity-responsive groups and bioorthogonal click chemistry to form large-sized aggregates in tumor tissue, which then slowly dissociated into ultrasmall nanoparticles for enhanced drug delivery. This system not only addressed hypoxia-induced chemoresistance and enhanced antitumor immune responses but also provided a general drug delivery strategy for improved tumor accumulation and penetration.

ACS NANO (2022)

Review Pharmacology & Pharmacy

Mechanisms of immune response to inorganic nanoparticles and their degradation products

Raziye Mohammapdour et al.

Summary: Research has elucidated the cellular and molecular mechanisms of interaction between inorganic nanoparticles and the immune system, with a specific focus on the immune response to the degradation products. The importance of designing new methods and instruments for assessing the safety of inorganic nanoparticles was emphasized.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Review Biochemistry & Molecular Biology

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

Chen Zhang et al.

Summary: Ferroptosis, an iron-dependent form of cell death, plays a crucial role in tumor suppression and has the potential to reverse cancer therapy resistance.

MOLECULAR CANCER (2022)

Review Immunology

Immunogenic cell stress and death

Guido Kroemer et al.

Summary: Immunogenic cell death (ICD) plays an important role in therapy and disease, as dying mammalian cells release signals that interact with the host to determine the immunological correlates of cellular stress and death. ICD is crucial in immunosurveillance and is related to strategies evolved by pathogens and cancer cells. Additionally, normal cell death can also initiate antigen-specific immune responses.

NATURE IMMUNOLOGY (2022)

Review Pharmacology & Pharmacy

Strategies targeting tumor immune and stromal microenvironment and their clinical relevance

Mengying Hu et al.

Summary: This article summarizes the important role of tumor microenvironment (TME) in tumor initiation and development, as well as the therapeutic approaches targeting TME. It is noted that there are many reviews focusing on TME remodeling therapies in animal models, but the up-to-date evaluation of TME-targeted therapeutics in clinical development is lacking. The article provides a detailed illustration of the opportunities for integrating nano-delivery system for the development of TME-specific therapeutic regimen and a comprehensive summary of approved or clinically evaluated therapeutics targeting cellular and extracellular components within tumor immune and stromal microenvironment, including small molecule and monoclonal antibody drugs as well as nanomedicines. The challenges and possible solutions for clinical translation of TME-targeted nanomedicines are also discussed.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Chemistry, Multidisciplinary

Strategies to improve the EPR effect: A mechanistic perspective and clinical translation

Mayumi Ikeda-Imafuku et al.

Summary: This review examines the key advances in strategies to enhance the extravasation and retention effect of nanoparticles, as well as analyzes the clinical trials and translation of these strategies.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Biochemical Research Methods

Formulation of two lipid-based membrane-core nanoparticles for FOLFOX combination therapy

Jianfeng Guo et al.

Summary: FOLFOX is an effective treatment for colorectal cancer and hepatocellular carcinoma, but its high toxicity limits the dosage. Two lipid-based nanoformulations, Nano-Folox and Nano-FdUMP, have been developed to lower toxicity and improve antitumor effect. The protocols for preparing these nanoformulations are described.

NATURE PROTOCOLS (2022)

Article Pharmacology & Pharmacy

A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer

Dandan Sun et al.

Summary: This study confirms the potential of ginsenoside Rg3 as an inducer of immunogenic cell death (ICD) against colorectal cancer (CRC) cells. The effectiveness of Rg3 in inducing ICD is significantly enhanced when combined with quercetin (QTN) that induces reactive oxygen species (ROS). A targeted nanoparticle formulation, co-encapsulating Rg3 and QTN, is developed to improve the in vivo delivery and shows enhanced tumor targeting and prolonged blood circulation in a CRC mouse model. The combination of this nanoparticle formulation with anti-PD-L1 leads to significantly longer survival in animals.

ACTA PHARMACEUTICA SINICA B (2022)

Review Chemistry, Multidisciplinary

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency

Zhilin Li et al.

Summary: This article reviews the use of nanostructure-based drug delivery systems (NDDSs) to enhance the effectiveness of tumor immunotherapy. By inducing immunogenic cell death (ICD) and releasing danger-associated molecular patterns (DAMPs) and tumor-associated antigens, in combination with chemotherapy, photodynamic therapy, photothermal therapy, and radiotherapy, the tumor immunosuppressive microenvironment can be improved, resulting in increased sensitivity to immunotherapy and reduced side effects.

ADVANCED SCIENCE (2022)

Article Chemistry, Multidisciplinary

Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy

Lijia Luo et al.

Summary: A lipid bilayer-coated mesoporous silica nanoparticle platform was developed for co-delivery of a TLR agonist and a chemotherapeutic agent, which improved the immune landscape in pancreatic cancer and achieved a positive therapeutic outcome.

ACS NANO (2022)

Article Engineering, Biomedical

Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy

Menghao Shi et al.

Summary: This study successfully engineered acidity-triggered nanoparticles to enhance tumor immunotherapy. The nanoparticles improved tumor penetration and cellular uptake, and released anti-tumor drugs and siRNA to activate the immune response for better anti-tumor capability.

ACTA BIOMATERIALIA (2022)

Article Chemistry, Multidisciplinary

Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier-Free Nanoassembly of Fluorinated Prodrug and siRNA

Pengkai Wu et al.

Summary: A carrier-free nanoparticle is developed to simultaneously deliver chemotherapeutic drug, cytolytic peptide, and anti-TOX small interfering RNA. This nanoparticle can regulate T cell exhaustion and infiltration, and stimulate a robust immune response.

ADVANCED MATERIALS (2022)

Article Chemistry, Multidisciplinary

Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer

Shulan Han et al.

Summary: This study confirmed the role of Plumbagin and Dihydrotanshinone I as inducers of immunogenic cell death in hepatocellular carcinoma (HCC) cells. The researchers developed a polymeric nanoparticle formulation that enhanced the delivery and tumor targeting of these drugs, leading to chemo-immunotherapeutic effects and significantly prolonged survival in HCC mice. This study provides a promising strategy for remodeling the immunosuppressive tumor microenvironment in liver cancer.

JOURNAL OF CONTROLLED RELEASE (2022)

Review Pharmacology & Pharmacy

Engineering nanosystems to overcome barriers to cancer diagnosis and treatment

Suhaila O. Alhaj-Suliman et al.

Summary: In the past two decades, there has been increasing interdisciplinary research on the development of nanoparticles for medical applications. However, nanoparticles still face biological barriers and biodistribution challenges, limiting their overall clinical potential. To overcome these limitations, innovative modifications have been made to nanoparticle formulations designed for cancer imaging and treatment, aiming to enhance specificity and target diseased tissues. Recent advancements in technology and chemistry have been employed to modify the surface and characteristics of nanoparticles, in combination with identifying critical biomarkers, providing new strategies for improving nanoparticle specificity in cancer diagnosis and therapy. This review discusses the latest advances in nanoparticle design and engineering, and outlines future directions for the development of next-generation nanomedicines.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Engineering, Biomedical

Smart pH-responsive polyhydralazine/bortezomib nanoparticles for remodeling tumor microenvironment and enhancing chemotherapy

Rui Wang et al.

Summary: This study presents a smart pH-responsive nanoparticle that can effectively enhance the accumulation of a drug in tumors by dilating tumor blood vessels. The nanoparticle demonstrates significant suppression of tumor growth, fewer side effects, and immune activation.

BIOMATERIALS (2022)

Article Chemistry, Multidisciplinary

Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer

Li Song et al.

Summary: A liposomal nanomedicine that modulates the tumor microenvironment has been developed to enhance cancer immunotherapy. By encapsulating metformin and an oxaliplatin prodrug in liposomes, this nanomedicine reduces tumor hypoxia and induces immunogenic cell death, effectively suppressing tumor growth and reversing immunosuppression.

JOURNAL OF CONTROLLED RELEASE (2022)

Review Biochemistry & Molecular Biology

Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy

Weitong Gao et al.

Summary: Immunotherapy has made significant breakthroughs in cancer treatment, but the poor response of some tumors limits its application. Inducing non-apoptotic regulated cell death (RCD) may convert these unresponsive tumors into those that respond to immunotherapy. Autophagy, ferroptosis, pyroptosis, and necroptosis have been found to have both inhibitory and synergistic effects on antitumor immune responses, suggesting that targeted therapies against these processes combined with immunotherapy may be effective even in resistant tumors.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Materials Science, Biomaterials

Stimuli-responsive cyclodextrin-based supramolecular assemblies as drug carriers

Ying Yuan et al.

Summary: This review summarizes the recent advances in stimuli-responsive supramolecular assemblies based on the host-guest chemistry of CDs. By integrating the host-guest chemistry of CDs with stimuli-responsive functions, various biomedical applications can be achieved in a spatiotemporally controlled manner.

JOURNAL OF MATERIALS CHEMISTRY B (2022)

Review Chemistry, Applied

Smart stimuli-responsive drug delivery systems based on cyclodextrin: A review

Bingren Tian et al.

Summary: Research in materials chemistry and medicine has led to the development of advanced drug delivery systems based on stimuli-responsive cyclodextrin. These systems respond to different stimuli such as pH, light, temperature, magnet, redox, and enzymes. Current research focuses on the classification, characteristics, and applications of these smart drug delivery systems.

CARBOHYDRATE POLYMERS (2021)

Article Engineering, Biomedical

IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment

Qilin Li et al.

Summary: This study introduces a nano system that co-delivers immunogenic chemodrugs and IDO inhibitors to cancer cells, effectively reducing immunosuppression and promoting antitumor immune responses. The system shows promising results in preclinical cancer models, indicating its strong translational potential for clinical applications.

BIOMATERIALS (2021)

Review Pharmacology & Pharmacy

Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery

Joydeb Majumder et al.

Summary: Nanocarriers offer multiple benefits in targeted drug delivery, such as enhanced bioavailability and high drug loading capacity. Stimuli-responsive nanocarriers have the potential to provide controlled release of therapeutics in response to specific physiological conditions or external stimuli.

EXPERT OPINION ON DRUG DELIVERY (2021)

Review Pharmacology & Pharmacy

A decade of cell death studies: Breathing new life into necroptosis

Imran Khan et al.

Summary: Programmed cell death (PCD) has been a major research interest in the past three decades. Initially, apoptosis was considered the only mechanistic pathway for PCD, but now other important pathways such as necroptosis have been discovered, which are crucial for understanding the cellular processes behind different pathological conditions. Additionally, research on triggering necroptosis in cancer cells to induce cell death and overcome chemoresistance is being discussed.

PHARMACOLOGY & THERAPEUTICS (2021)

Review Pharmacology & Pharmacy

Nanomedicine from amphiphilized prodrugs: Concept and clinical translation

Jiajia Xiang et al.

Summary: Nanomedicines, composed of carrier materials and small amounts of active pharmaceutical ingredients, have been widely used to improve therapeutic effects and reduce side effects. Converting hydrophobic/hydrophilic drugs into prodrugs capable of self-assembly into nanostructures offers many advantages, including high drug loading efficiency and controlled release. This review comprehensively summarizes recent advances in APDs and their nanomedicines, as well as the challenges and future prospects.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Chemistry, Multidisciplinary

Hybrid Nanosystems for Biomedical Applications

Joshua Seaberg et al.

Summary: Inorganic/organic hybrid nanosystems have been increasingly developed for their versatility and efficacy in biomedical applications, including gene therapy, drug delivery, and phototherapy. They can be classified based on their components and architecture, showing potential for diverse utility and innovation in the future.

ACS NANO (2021)

Review Pharmacology & Pharmacy

Nanodelivery of immunogenic cell

Dandan Sun et al.

DRUG DISCOVERY TODAY (2021)

Article Biochemistry & Molecular Biology

Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma

Jianfeng Guo et al.

Summary: This study demonstrates the concept of successful FOLFOX-associated CRC and HCC therapies through the combination of two nano delivery systems. Further optimization in dosing and timing has the potential to enhance the clinical efficacy of this combination strategy.

MOLECULAR CANCER (2021)

Review Biochemistry & Molecular Biology

Systematic Review of Cancer Targeting by Nanoparticles Revealed a Global Association between Accumulation in Tumors and Spleen

Andrey S. Drozdov et al.

Summary: This study explores the active targeting of nanoparticles towards tumors, analyzing factors influencing efficient targeting and therapy. It reveals that increased tumor accumulation of targeted nanoparticles coincides with decreased uptake by the spleen, with no correlation between changes in nanoparticle concentration in tumors versus other organs. Moreover, the study highlights the impact of targeting molecules and nanoparticle type on splenic and tumor accumulation, showing that combinatorial targeting of nanoparticle drugs leads to higher treatment efficiencies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Atypical Renal Clearance of Nanoparticles Larger Than the Kidney Filtration Threshold

Christophorus F. Adhipandito et al.

Summary: Recent studies found nanoparticles larger than the kidney filtration threshold remaining intact in the urine of laboratory mice, challenging the known size limit for renal clearance. This raises questions on what types of nanoparticles can bypass the filtration barrier, essential physical and chemical characteristics required, as well as the biomolecular and cellular mechanisms involved.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Multidisciplinary

Combination Chemo-Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti-PD-1

Xiangsheng Liu et al.

Summary: Improving irinotecan delivery using a lipid bilayer coated mesoporous silica nanoparticle, known as a silicasome, can enhance PDAC survival through a chemo-immunotherapy response in a Kras-dependent pancreatic cancer model. This method triggers a cascade of events including autophagy inhibition, endoplasmic reticulum stress, immunogenic cell death (ICD), and PD-L1 expression. The chemo-immunotherapy response elicited by the silicasome is more robust than traditional drug delivery methods and can be synergistically enhanced with anti-PD-1 therapy.

ADVANCED SCIENCE (2021)

Article Engineering, Biomedical

Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy

Lisi Xie et al.

Summary: The study created a novel phenolic inducer through self-assembly, which enhances cell death triggered by doxorubicin and accelerates immunogenic cell death (ICD) induction, leading to increased infiltration of tumor-specific T cells and improved tumor response to PD-1 checkpoint blockade immunotherapy.

BIOMATERIALS (2021)

Article Engineering, Biomedical

Point-source burst of coordination polymer nanoparticles for tri-modality cancer therapy

Xiang Ling et al.

Summary: This study presents a novel core-shell nanoscale coordination polymer particle design for tri-modality cancer therapy, which efficiently suppresses cancer growth and metastasis through reactivating immune responses.

BIOMATERIALS (2021)

Article Chemistry, Multidisciplinary

Oxygen and oxaliplatin-loaded nanoparticles combined with photo-sonodynamic inducing enhanced immunogenic cell death in syngeneic mouse models of ovarian cancer

Jiao Zheng et al.

Summary: This study successfully fabricated phase-changeable core-shell nanoparticles, which have great potential for enhancing photoacoustic imaging. By combining chemotherapy and photo-sonodynamic therapy, the treatment strategy induced immunogenic cell death and significantly enhanced antitumor immunity, inhibiting the growth of ovarian cancer.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Chemistry, Multidisciplinary

Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy

Fatemeh Oroojalian et al.

Summary: Nanotechnology offers promising opportunities for cancer management, particularly through biomimetic approaches using immune cell membranes to coat nanoparticles for improved stability and targeting; the surface proteins from immune cells can provide various functionalities to nanoparticles, enhancing their efficacy and reducing toxicity.

SMALL (2021)

Article Engineering, Biomedical

Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity

Suah Yang et al.

Summary: The construction of cancer-activated DOX prodrug nanoparticles provides a promising approach to enhance anticancer immune responses while minimizing side effects and systemic immunosuppression. These nanoparticles selectively target cancer cells, inducing cytotoxicity and immunogenic cell death, leading to increased response to checkpoint inhibitor immunotherapy.

BIOMATERIALS (2021)

Article Chemistry, Multidisciplinary

Cooperative Self-Assembled Nanoparticle Induces Sequential Immunogenic Cell Death and Toll-Like Receptor Activation for Synergistic Chemo-immunotherapy

Yaoqi Wang et al.

Summary: The study engineered sequential pH/redox-responsive nanoparticles to activate the immune microenvironment of tumors and lymph nodes, enhancing the antitumor immune response and providing a potential candidate for synergistic cancer chemo-immunotherapy.

NANO LETTERS (2021)

Review Pharmacology & Pharmacy

Liposome composition in drug delivery design, synthesis, characterization, and clinical application

Danielle E. Large et al.

Summary: Liposomal drug delivery is a highly adaptable therapeutic platform for treating a wide range of diseases. The molecular diversity in liposome composition enables drug delivery with unique physiological functions, such as pH response and reduced systemic toxicity.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Chemistry, Multidisciplinary

Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway

Yuan Ding et al.

Summary: Clinical trials have shown that combining IDO blockade with immunogenic chemotherapy has great potential in cancer therapy. A hybrid nanomedicine was designed to co-deliver an IDO inhibitor and a chemotherapeutic prodrug, effectively activating chemo-immunotherapy and overcoming the immunosuppressive tumor microenvironment, leading to tumor growth suppression.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer

Feiyang Jin et al.

Summary: The combined application of anti-CD73 antibody and chemo-PDT can enhance the anti-metastatic effects of T cell-mediated antitumor immunity synergistically. This strategy not only prevents abscopal tumor metastasis but also induces a series of immunogenic cell death, leading to tumor-specific immunity.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Chemistry, Multidisciplinary

Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction

Ming Zhao et al.

Summary: The development of twin-like charge-switchable nanoparticles provides a selective delivery system for targeting tumor-associated macrophages and cancer cells, reversing the immunosuppressive tumor microenvironment and enhancing the effectiveness of cancer immunotherapy.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Nanoscience & Nanotechnology

Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy

Zhiren Wang et al.

Summary: Despite the potential of immune checkpoint blockade, it only benefits a small subset of patients. The nano-based platform for co-delivery of chemo- and immunotherapeutics shows efficient synergic antitumour activity in large, hard-to-treat tumour models.

NATURE NANOTECHNOLOGY (2021)

Review Chemistry, Multidisciplinary

Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery

Guanting Li et al.

Summary: SMP-NAs, formed by the self-assembly of prodrugs, have been widely investigated for their ultrahigh drug-loading and minimal adverse reactions, offering potential for improved antitumor efficiency compared to traditional nanomedicines. They are being used in chemotherapy, phototherapy, immunotherapy, and tumor diagnosis, and their co-delivery capabilities can address the challenges of tumor heterogeneity and multidrug resistance. Smart stimuli-responsive SMP-NAs and combination therapies based on SMP-NAs are also highlighted, emphasizing the structure-function relationships.

SMALL (2021)

Article Chemistry, Multidisciplinary

Coordination and Redox Dual-Responsive Mesoporous Organosilica Nanoparticles Amplify Immunogenic Cell Death for Cancer Chemoimmunotherapy

Fan Zhang et al.

Summary: The potential ICD nanoamplifier containing diselenide-bridged mesoporous organosilica nanoparticles (MONs) and chemotherapeutic ruthenium compound (KP1339) showed controlled drug release profiles and evoked robust antitumor immunological responses by amplifying ICD of KP1339.

SMALL (2021)

Article Chemistry, Multidisciplinary

Reinforcing the Induction of Immunogenic Cell Death Via Artificial Engineered Cascade Bioreactor-Enhanced Chemo-Immunotherapy for Optimizing Cancer Immunotherapy

Kai Sun et al.

Summary: Traditional chemo-immunotherapy can induce T cell immune response through immunogenic cell death (ICD), but the limited ICD hinders lasting antitumor immunotherapeutic efficacy. A novel tadpole-ovoid Au@HMnMSNs nanoreactor is constructed to generate intratumoral hydroxyl radicals for enhanced ICD induction and DC maturation, along with DOX and ASA for recruitment of immune cells and inhibition of immunosuppressive cells.

SMALL (2021)

Review Immunology

Immunogenic Cell Death-Based Cancer Vaccines

Ming-Zhu Jin et al.

Summary: Cancer immunotherapy has made significant progress, but is limited in immunologically cold tumors. Inducing immunogenic cell deaths (ICDs) is seen as an attractive approach to activate antitumor immunity. ICD-based cancer vaccines mimic the effect of cancer vaccines but face challenges.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Pyroptosis: mechanisms and diseases

Pian Yu et al.

Summary: Pyroptosis has gained attention for its association with innate immunity and diseases. The discovery of the gasdermin family has expanded the research scope of pyroptosis, revealing its potential effects on tumor development. Pyroptosis serves as a double-edged sword in tumors, with the rational utilization of its dual effect providing insights for new drug development and understanding tumor formation and progression.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Engineering, Biomedical

Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy

Defu Zhi et al.

ACTA BIOMATERIALIA (2020)

Review Medicine, Research & Experimental

How Corona Formation Impacts Nanomaterials as Drug Carriers

Munishwar Nath Gupta et al.

MOLECULAR PHARMACEUTICS (2020)

Review Biotechnology & Applied Microbiology

Cell membrane-coated nanoparticles: research advances

Shuaijun Zou et al.

NANOMEDICINE (2020)

Review Chemistry, Multidisciplinary

Engineering the Bio-Nano Interface Using a Multifunctional Coordinating Polymer Coating

Wentao Wang et al.

ACCOUNTS OF CHEMICAL RESEARCH (2020)

Review Pharmacology & Pharmacy

Membrane-core nanoparticles for cancer nanomedicine

Jianfeng Guo et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Review Oncology

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Lorenzo Galluzzi et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Review Biochemistry & Molecular Biology

Mouse Tumor Models for Advanced Cancer Immunotherapy

Dania S. Chulpanova et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity

Rong Tang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Review Chemistry, Multidisciplinary

Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy

Lei Zhou et al.

ACCOUNTS OF CHEMICAL RESEARCH (2020)

Review Oncology

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Lorenzo Galluzzi et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Cell Biology

Emerging connectivity of programmed cell death pathways and its physiological implications

Sammy Bedoui et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Review Nanoscience & Nanotechnology

A Review on the Synthesis and Functionalization of Gold Nanoparticles as a Drug Delivery Vehicle

Sundus Jabeen Amina et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Review Medicine, Research & Experimental

Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies

Yun Liu et al.

THERANOSTICS (2020)

Review Materials Science, Biomaterials

Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery

Huaiji Wang et al.

BIOMATERIALS SCIENCE (2020)

Review Cell Biology

Cell death: a review of the major forms of apoptosis, necrosis and autophagy

Mark S. D'Arcy

CELL BIOLOGY INTERNATIONAL (2019)

Review Chemistry, Multidisciplinary

Threatening cancer with nanoparticle aided combination oncotherapy

Shruti Rawal et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Review Biochemistry & Molecular Biology

The role of necroptosis in cancer biology and therapy

Yitao Gong et al.

MOLECULAR CANCER (2019)

Review Pharmacology & Pharmacy

Optimizing Advances in Nanoparticle Delivery for Cancer Immunotherapy

Joseph M. Caster et al.

ADVANCED DRUG DELIVERY REVIEWS (2019)

Article Chemistry, Multidisciplinary

Green Nanotechnology-Driven Drug Delivery Assemblies

Rohini Kanwar et al.

ACS OMEGA (2019)

Article Chemistry, Multidisciplinary

Poly(β-amino ester)-based gene delivery systems: From discovery to therapeutic applications

Rosemeyre A. Cordeiro et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Review Pharmacology & Pharmacy

Design strategies for chemical-stimuli-responsive programmable nanotherapeutics

Muhammad Gulfam et al.

DRUG DISCOVERY TODAY (2019)

Review Engineering, Biomedical

Nanocarriers and Their Loading Strategies

Neng Wang et al.

ADVANCED HEALTHCARE MATERIALS (2019)

Review Pharmacology & Pharmacy

Nanocarrier-based systems for targeted and site specific therapeutic delivery

Joydeb Majumder et al.

ADVANCED DRUG DELIVERY REVIEWS (2019)

Review Medicine, Research & Experimental

Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment

Jooho Park et al.

THERANOSTICS (2019)

Review Pharmacology & Pharmacy

Microfluidics for producing poly (lactic-co-glycolic acid)-based Check for pharmaceutical nanoparticles

Xuanyu Li et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Article Biochemistry & Molecular Biology

eIF2α phosphorylation is pathognomonic for immunogenic cell death

Lucillia Bezu et al.

CELL DEATH AND DIFFERENTIATION (2018)

Review Chemistry, Multidisciplinary

Block Copolymer Micelles in Nanomedicine Applications

Horacio Cabral et al.

CHEMICAL REVIEWS (2018)

Review Pharmacology & Pharmacy

Light-triggerable formulations for the intracellular controlled release of biomolecules

Miguel M. Lino et al.

DRUG DISCOVERY TODAY (2018)

Review Pharmacology & Pharmacy

Strategies for the enhanced intracellular delivery of nanomaterials

Claudia Azevedo et al.

DRUG DISCOVERY TODAY (2018)

Review Pharmacology & Pharmacy

Advances and applications of block-copolymer-based nanoformulations

Vibhuti Agrahari et al.

DRUG DISCOVERY TODAY (2018)

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Review Pharmacology & Pharmacy

Mesoporous silica nanoparticles for drug and gene delivery

Yixian Zhou et al.

ACTA PHARMACEUTICA SINICA B (2018)

Review Biochemistry & Molecular Biology

Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic

Samer Bayda et al.

CURRENT MEDICINAL CHEMISTRY (2018)

Review Pharmacology & Pharmacy

Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release

Aldemar Gordillo-Galeano et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)

Review Oncology

Mouse Models for Cancer Immunotherapy Research

Brian Olson et al.

CANCER DISCOVERY (2018)

Review Pharmacology & Pharmacy

Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems

Vijay Mishra et al.

PHARMACEUTICS (2018)

Review Nanoscience & Nanotechnology

A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine

Hossein Jahangirian et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Review Biotechnology & Applied Microbiology

Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern

Pik-Ling Lam et al.

NANOMEDICINE (2017)

Review Materials Science, Biomaterials

Cyclodextrin-based biological stimuli-responsive carriers for smart and precision medicine

Rongqiang Liao et al.

BIOMATERIALS SCIENCE (2017)

Editorial Material Chemistry, Medicinal

Parameters Affecting the Enhanced Permeability and Retention Effect: The Need for Patient Selection

Az Alddien Natfji et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2017)

Review Oncology

Transport of drugs from blood vessels to tumour tissue

Mark W. Dewhirst et al.

NATURE REVIEWS CANCER (2017)

Review Peripheral Vascular Disease

Tumor angiogenesis and vascular normalization: alternative therapeutic targets

Claire Viallard et al.

ANGIOGENESIS (2017)

Review Oncology

Microenvironmental regulation of tumour angiogenesis

Michele de Palma et al.

NATURE REVIEWS CANCER (2017)

Article Immunology

Programmed cell death and the immune system

Shigekazu Nagata et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Pharmacology & Pharmacy

Polysaccharide-based nanoparticles for theranostic nanomedicine

M. Swierczewska et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Review Pharmacology & Pharmacy

Extracellular matrix structure

Achilleas D. Theocharis et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Review Pharmacology & Pharmacy

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

Jung Soo Suk et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Editorial Material Cell Biology

How autophagy both activates and inhibits cellular senescence

Chanhee Kang et al.

AUTOPHAGY (2016)

Review Biochemistry & Molecular Biology

Endoplasmic Reticulum Stress and Associated ROS

Hafiz Maher Ali Zeeshan et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Chemistry, Multidisciplinary

Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination

Yi-Nan Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

Article Pharmacology & Pharmacy

Safety of Nanoparticles in Medicine

Joy Wolfram et al.

CURRENT DRUG TARGETS (2015)

Article Gastroenterology & Hepatology

Stromal biology and therapy in pancreatic cancer: a changing paradigm

Albrecht Neesse et al.

Article Medicine, Research & Experimental

Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation

Xiaorong Zhu et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Biotechnology & Applied Microbiology

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Elvin Blanco et al.

NATURE BIOTECHNOLOGY (2015)

Review Cell Biology

Remodelling the extracellular matrix in development and disease

Caroline Bonnans et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

Review Pharmacology & Pharmacy

Prodrug-based nanoparticulate drug delivery strategies for cancer therapy

Cong Luo et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2014)

Review Pharmacology & Pharmacy

Inorganic nanosystems for therapeutic delivery: Status and prospects

Chang Soo Kim et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Review Pharmacology & Pharmacy

Liposomal drug delivery systems: From concept to clinical applications

Theresa M. Allen et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Review Immunology

Immunogenic Cell Death in Cancer Therapy

Guido Kroemer et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)

Review Biochemistry & Molecular Biology

Inducers of immunogenic cancer cell death

Aleksandra M. Dudek et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2013)

Review Pharmacology & Pharmacy

The influence of nanostructured materials on biointerfacial interactions

Peter Koegler et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Article Oncology

p53/HMGB1 Complexes Regulate Autophagy and Apoptosis

Kristen M. Livesey et al.

CANCER RESEARCH (2012)

Article Biochemistry & Molecular Biology

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

Abhishek D. Garg et al.

EMBO JOURNAL (2012)

Article Cell Biology

Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death

Laurie Menger et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Article Multidisciplinary Sciences

CD91-dependent programming of T-helper cell responses following heat shock protein immunization

Sudesh Pawaria et al.

NATURE COMMUNICATIONS (2011)

Article Biochemistry & Molecular Biology

Immunogenic death of colon cancer cells treated with oxaliplatin

A. Tesniere et al.

ONCOGENE (2010)

Review Pharmacology & Pharmacy

Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers

Younsoo Bae et al.

ADVANCED DRUG DELIVERY REVIEWS (2009)

Article Biochemistry & Molecular Biology

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors

Francois Ghiringhelli et al.

NATURE MEDICINE (2009)

Review Biotechnology & Applied Microbiology

Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats

Michelle Longmire et al.

NANOMEDICINE (2008)

Article Biotechnology & Applied Microbiology

Renal clearance of quantum dots

Hak Soo Choi et al.

NATURE BIOTECHNOLOGY (2007)

Article Biochemistry & Molecular Biology

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Lionel Apetoh et al.

NATURE MEDICINE (2007)

Review Pharmacology & Pharmacy

Endocytic mechanisms for targeted drug delivery

Lisa A. Bareford et al.

ADVANCED DRUG DELIVERY REVIEWS (2007)

Article Anatomy & Morphology

Contribution of high-resolution correlative imaging techniques in the study of the liver sieve in three-dimensions

Filip Braet et al.

MICROSCOPY RESEARCH AND TECHNIQUE (2007)

Article Biochemistry & Molecular Biology

Calreticulin exposure dictates the immunogenicity of cancer cell death

Michel Obeid et al.

NATURE MEDICINE (2007)

Review Chemistry, Multidisciplinary

Lipid-based nanoparticles for nucleic acid delivery

Weijun Li et al.

PHARMACEUTICAL RESEARCH (2007)

Article Immunology

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

N Casares et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Review Immunology

The three Es of cancer immunoediting

GP Dunn et al.

ANNUAL REVIEW OF IMMUNOLOGY (2004)